课题基金 / 基金详情

LINOLEIC ACID METABOLISM AND COLON CARCINOGENESIS

LINOLEIC ACID METABOLISM AND COLON CARCINOGENESIS
亚油酸代谢与结肠癌发生
批准号:
6630445
负责人:
Imad Shureiqi
金额:
$13.61万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-08-01 至 2005-07-31

项目摘要

项目成果

Imad Shureiqi的其他基金

相似基金

相关文献

中文摘要
翻译
这位候选人寻求在癌症化学预防领域发展他的翻译研究人员的职业生涯,他现在的工作环境非常有利于这类研究。这项提议为候选人制定化学预防研究的多学科转换方法的计划提供了框架。需要更好的干预措施来预防结肠癌的高死亡率。亚油酸(LA)是一种常见的膳食多不饱和脂肪酸,可转化为花生四烯酸(AA),花生四烯酸(AA)可形成有丝分裂代谢产物[如前列腺素E_2(PGE_2)和白三烯B_4(LTB_4)]。La也是15-脂氧合酶-1(15-LOX-1)形成13-S-羟基十八烯酸(13-S-HODE)的底物。我们发现15-LOX-1和13-S-HODE在人结肠癌中被还原,13-S-HODE诱导转化的结肠细胞凋亡。在正常细胞中,D-6-脱饱和酶(d-6-d)形成伽马-亚麻酸(GLA),启动LA向AA的转化。许多肿瘤细胞缺乏d-6-d活性,并因暴露于GLA而死亡。一些证据表明,肿瘤细胞通过另一种途径将LA转化为AA,这需要增量5-去饱和酶(d-5-d)。该假说认为,亚油酸代谢从产生促凋亡产物[13-S-HODE和(GLA)]转变为形成花生四烯酸的有丝分裂代谢产物(如前列腺素E_2和L_(TB_4)),对结肠癌的发生有重要贡献。其具体目的是:1)确定替代转化途径的活性与结肠细胞体外转化和分化状态的关系;2)使用临床观察性研究模型(通过测定3组患者[正常、息肉和结肠癌]中LA替代途径的活性和LA和AA的相关酶和代谢物[如13-S-HoDe、PGE_2、LTB_4、d-6-d和15-lox-1]的水平),评价LA代谢变化与人类结肠癌发生的关系;3)研究d-6-d的异位表达对转化的结肠细胞的凋亡、分化和LA代谢的影响;4)评价选择性d-5-d抑制对LA代谢和转化的结肠细胞存活的影响;5)建立大鼠结肠癌的短期实验方法,以确定选择性d-5-d抑制对大鼠结肠癌发生的影响。这项工作将为未来LA替代途径调控作为结肠癌化学预防手段的动物和临床研究奠定基础。
英文摘要
The candidate seeks to develop his career as a translational researcher in the field of cancer chemoprevention and he is now working in an environment highly conducive to such research. This proposal provides the framework for the candidate's plans to develop a multidisciplinary translational approach to chemoprevention research. Better interventions are needed to prevent the high mortality of colon cancer. Linoleic acid (LA), a common dietary polyunsaturated fatty acid, can be convertted to arachidonic acid (AA) that can in turn form mitogenic metabolites [e.g. prostaglandin, E2 (PGE2) and leukotriene B4 (LTB4)]. LA is also the substrate for 15-lipoxygenase-1 (15-lox-1) in forming 13-S-hydroxyoctadecadienoic (13-S-HODE). We have found that 15- lox-1 and 13-S-HODE are reduced in human colon cancers and that 13-S-HODE induces apoptosis in transformed colonic cells. In normal cells, the enzyme delta 6-desaturase (d-6-d) forms gamma- linolenic acid (GLA) to start the conversion of LA to AA. Many tumor cells lack d-6-d activity and die by GLA exposure. Some evidence suggests tumor cells convert LA to AA by an alternative pathway that requires delta 5-desaturase (d-5-d). The hypothesis is that a shift in linoleic metabolism from producing pro- apoptosis products [13-S-HODE and (GLA)] to the formation of mitogenic metabolites of arachidonic acid (e.g. PGE2 and LTB4) significantly contributes to colonic carcinogenesis. The specific aims are 1) to determine the activity of the alternative conversion pathway in relation to the transformation and differentiation states of colonic cells in vitro; 2) to evaluate the association between the shift in LA metabolism and the progressive steps of human colonic carcinogenesis using a clinical observational study model(by measuring the activity of LA alternative pathway and levels of related enzymes and metabolites of LA and AA [e.g. 13-S-HODE, PGE2, LTB4, d-6-d, and 15-lox-1] in colonic tissues from 3 patient groups [normal, polyp, and colon cancers]); 3) to evaluate the effects of ectopic d-6-d expression on apoptosis, differentiation, and LA metabolism in transformed colonic cells in vitro; 4) to evaluate the impact of selective d-5-d inhibition on LA metabolism and the survival of transformed colonic cells in-vitro; and 5) to determine the effects of selective d-5-d inhibition on colon carcinogenesis in an established short-term assay in rats. This work will set the stage for future animals and clinical studies of LA alternative pathway modulation as means of colon cancer chemoprevention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolism
ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolism
15-LOX-1 Modulation of Colon Cancer Promotion by Linoleic Acid
15-LOX-1 regulation of resolving generation to modulate colon cancer
海外基金